Figure 2.
Representation of ranked differences in levels of IL-17A between implant and tooth sites for 73 participants, indicating that IL-17A levels at the implant site tended to be greater than those at the tooth site. Higher PISF levels of IL-17A relative to GCF (red bars) were found in 61.6% of participants (sign test, p=0.023).